Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice.
Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V; CoRISpe Working Group. Palladino C, et al. AIDS. 2015 Oct 23;29(16):2155-9. doi: 10.1097/QAD.0000000000000819. AIDS. 2015. PMID: 26544580
Linezolid-containing Treatment Regimens for Tuberculosis in Children.
Prieto LM, Santiago B, Del Rosal T, Carazo B, Jiménez AB, Pérez-Gorricho B, Rubio F, Tagarro A, Blázquez-Gamero D, Moreno-Pérez D, Mellado MJ, Baquero-Artigao F; Spanish Paediatric TB Research Network (pTBred). Prieto LM, et al. Pediatr Infect Dis J. 2019 Mar;38(3):263-267. doi: 10.1097/INF.0000000000002093. Pediatr Infect Dis J. 2019. PMID: 29750764
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Tejedor JC, et al. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7. doi: 10.1097/INF.0b013e318269433a. Pediatr Infect Dis J. 2012. PMID: 22828645 Clinical Trial.
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.
Cressey TR, Green H, Khoo S, Treluyer JM, Compagnucci A, Saidi Y, Lallemant M, Gibb DM, Burger DM; Paediatric European Network for Treatment of AIDS II Study Group. Cressey TR, et al. Clin Infect Dis. 2008 May 15;46(10):1601-8. doi: 10.1086/587657. Clin Infect Dis. 2008. PMID: 18419497 Free PMC article. Clinical Trial.
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
Klein N, Sefe D, Mosconi I, Zanchetta M, Castro H, Jacobsen M, Jones H, Bernardi S, Pillay D, Giaquinto C, Walker AS, Gibb DM, De Rossi A; Paediatric European Network for Treatment of AIDS 11 Trial Team. Klein N, et al. PLoS One. 2013 Oct 23;8(10):e76582. doi: 10.1371/journal.pone.0076582. eCollection 2013. PLoS One. 2013. PMID: 24194841 Free PMC article. Clinical Trial.
[Child hospital admissions associated with influenza virus infection in 6 Spanish cities (2014-2016)].
Arístegui Fernández J, González Pérez-Yarza E, Mellado Peña MJ, Rodrigo Gonzalo de Liria C, Hernández Sampelayo T, García García JJ, Ruiz Contreras J, Moreno Pérez D, Garrote Llanos E, Ramos Amador JT, Cilla Eguiluz CG, Méndez Hernández M; en representación del grupo de estudio HOSPIGRIP; Autores del grupo de estudio HOSPIGRIP. Arístegui Fernández J, et al. An Pediatr (Engl Ed). 2019 Feb;90(2):86-93. doi: 10.1016/j.anpedi.2018.06.012. Epub 2018 Jul 25. An Pediatr (Engl Ed). 2019. PMID: 30055938 Free article. Spanish.
147 results